19 results
8-K
EX-99.1
PSTV
Plus Therapeutics Inc
13 Mar 24
Regulation FD Disclosure
8:01am
primary tumor Chemoresistance Complex Anatomy Surgical Therapy Inadequate MGMT status and acquired Getting ‘drug on tumor’ more Clean surgical margins
POS AM
EX-1.1
PSTV
Plus Therapeutics Inc
6 Jul 18
Prospectus update (post-effective amendment)
7:31pm
of public health, protection of worker health and safety, or the handling of hazardous materials, including without limitation, the Clean Air Act, 42 U.S.C
8-K
EX-99.1
PSTV
Plus Therapeutics Inc
4 Mar 15
Results of Operations and Financial Condition
12:00am
cancer, clean margins, no recurrence MethodECCI-50 + fat injected into rhabdosphincter and submucosal space of urethraResultsAt 12 months
8-K/A
EX-99.1
tpqc4zx mli6
4 Mar 15
Results of Operations and Financial Condition
12:00am
8-K
EX-10.2
qdpm12gqkdvh z1wa8z
8 Oct 14
Cytori Therapeutics, Inc. to Raise $13.5 Million in Registered Direct Offering
12:00am
8-K
EX-1.1
45k4w11xl
14 Dec 12
Cytori Therapeutics Proposes Public Offering of Common Stock
12:00am
8-K
EX-1.1
lt517ihuym9z2
8 Oct 10
Cytori Therapeutics Proposes Common Stock Public Offering
12:00am
8-K
EX-10.64
q53 687ntkcmrxs9jvx
10 Mar 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
pjboqxq9ckki2lv
26 Feb 07
Entry into a Material Definitive Agreement
12:00am
FWP
y0oqjjx0 i7
26 Feb 07
Free writing prospectus
12:00am
8-K
EX-10
pmem5cwgq
15 Aug 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
89xo rpgb
23 Oct 02
Acquisition or disposition of assets
12:00am
- Prev
- 1
- Next